We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

61 hedge funds and large institutions have $2.45M invested in Oncolytics Biotech in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

9% more funds holding

Funds holding: 56 → 61 (+5)

0.02% less ownership

Funds ownership: 2.81% → 2.79% (-0.02%)

35% less capital invested

Capital invested by funds: $3.77M → $2.45M (-$1.32M)

Holders
61
Holders Change
+5
Holders Change %
+8.93%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
9
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Connective Capital Management
California
+$162K
2
XT
XTX Topco
Cayman Islands
+$85K
3
VF
Virtu Financial
New York
+$84.2K
4
TAM
Tocqueville Asset Management
New York
+$77.8K
5
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$54K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$535K
2
QC
Quadrature Capital
United Kingdom
-$146K
3
Marshall Wace
Marshall Wace
United Kingdom
-$66.8K
4
Goldman Sachs
Goldman Sachs
New York
-$41.9K
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
51
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
Bank of America
52
Bank of America
North Carolina
$874 – – –
MCM
53
MAI Capital Management
Ohio
$460 – – –
TWC
54
TD Waterhouse Canada
Ontario, Canada
$353 – – –
SIS
55
Sound Income Strategies
Florida
$196 – – –
JFA
56
JNBA Financial Advisors
Minnesota
$184 – – –
DWM
57
Dogwood Wealth Management
Kansas
$128 – – –
AF
58
Aviso Financial
Ontario, Canada
$45 – – –
IPS
59
Investors Portfolio Services
Washington
$37 +$45 +42 New
WWM
60
Wolff Wiese Magana
California
$28 – – –
Citigroup
61
Citigroup
New York
$1 +$1 +1 New
Citadel Advisors
62
Citadel Advisors
Florida
– -$535K -382,051 Closed
QC
63
Quadrature Capital
United Kingdom
– -$146K -106,076 Closed
Cambridge Investment Research Advisors
64
Cambridge Investment Research Advisors
Iowa
– -$35K -24,771 Closed
RC
65
Rovin Capital
Arizona
– -$29K -20,620 Closed
SRL
66
Scientech Research LLC
New Jersey
– -$25.5K -18,204 Closed
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
– -$4.04K -2,884 Closed
IA
68
IFP Advisors
Florida
– -$140 -100 Closed
1 2
3

ONCY Hedge Fund Activity: Q4 2025 in Review

61 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q4 2025, worth a combined $2.45M — down 35% from $3.77M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ONCY positions and 7 closed out — a net gain of 6 holders — while 9 added to existing stakes and 5 trimmed.

The largest buyer was Connective Capital Management, opening a new position worth an estimated $162K. The largest seller was Citadel Advisors, exiting entirely with an estimated $535K sold.

  • 61 institutional investors held Oncolytics Biotech (ONCY) as of Q4 2025, up from 56 in Q3 2025.
  • Funds reported $2.45M of Oncolytics Biotech stock for Q4 2025, down 35% quarter-over-quarter.
  • 13 funds opened new Oncolytics Biotech positions in Q4 2025 and 7 closed out, a net change of +6 holders.
  • The largest Oncolytics Biotech buyer in Q4 2025 was Connective Capital Management, an estimated $162K added.
  • The largest Oncolytics Biotech seller in Q4 2025 was Citadel Advisors, an estimated $535K sold.

Based on aggregated 13F filings for Q4 2025.